RetinalGenix Technologies Inc. (RTGN)

USD 53.0

(88.0%)

Revenue Summary of RetinalGenix Technologies Inc.

  • RetinalGenix Technologies Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • RetinalGenix Technologies Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • RetinalGenix Technologies Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • RetinalGenix Technologies Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • RetinalGenix Technologies Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • RetinalGenix Technologies Inc. reported a quarterly revenue of - USD for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of RetinalGenix Technologies Inc. (2023 - 2018)

Historical Annual Revenue of RetinalGenix Technologies Inc. (2023 - 2018)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%

Peer Revenue Comparison of RetinalGenix Technologies Inc.

Name Revenue Revenue Difference
Acutus Medical, Inc. 7.16 Million USD 100.0%
Biotricity, Inc. 12.06 Million USD 100.0%
Cell MedX Corp. - USD NaN%
Dynatronics Corporation 32.53 Million USD 100.0%
Nemaura Medical Inc. 77.04 Thousand USD 100.0%
PetVivo Holdings, Inc. 968.7 Thousand USD 100.0%
Sonendo, Inc. 43.86 Million USD 100.0%
Telesis Bio, Inc. 27.5 Million USD 100.0%
Talis Biomedical Corporation 412 Thousand USD 100.0%
Viveve Medical, Inc. 6.42 Million USD 100.0%